About
Zhanqi is an Associate in our Global Transactions group in Hong Kong. His practice focuses on equity and debt capital markets matters, including SEC-registered offerings, Rule 144A and Regulation S offerings and listings in New York and Hong Kong. He also advises on SEC compliance and reporting, corporate governance, and other general corporate matters. Prior to joining us in Hong Kong, Zhanqi was an associate in the firm’s New York office.
Additional Information
- Hesai Group on its US$540 million Hong Kong dual primary listing and SEC-registered offering
- Sunshine Lake Pharma on its privatization of YiChang HEC Pharmaceutical and the concurrent listing on HKSE
- Lens Technology on its US$607 million listing on HKSE
- Oracle Corporation on its SEC-registered offering of $6.25 billion aggregate principal amount of senior notes
- Oracle Corporation on its SEC-registered offering of $7 billion aggregate principal amount of senior notes
- Oracle Corporation on its SEC-registered offering $5.25 billion aggregate principal amount of senior notes
- Stagwell on its $108 million debut secondary offering
- Verlinvest S.A. in connection with a comprehensive financing by Oatly Group AB
- Coupa on its $8 billion sale to Thoma Bravo
- EVgo on its $125 million follow-on offering
Zhanqi Xu
Associate
Hong Kong Office
55th Floor, One Island East
Taikoo Place, Quarry Bay
Hong Kong